Get started
Live feed
INSIDERFilingvia Quantisnow
Aeglea BioTherapeutics Inc. logo

Aeglea BioTherapeutics (AGLE): SEC Form 3: New insider Kastenmayer James Paul claimed ownership of 4,000 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Aeglea BioTherapeutics Inc. logo
AGLE
Aeglea BioTherapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2016
Get push alerts for AGLE

Follow AGLE and get a push notification the moment its next story breaks.

Full AGLE profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGLE (Aeglea BioTherapeutics Inc.) and more on Quantisnow.